Fertility and Sterility
Volume 82, Issue 4 , Pages 841-846, October 2004

Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization

Presented at the 58th Annual Meeting of the American Society for Reproductive Medicine, Seattle, Washington, October 12–17, 2002.

The Center for Advanced Reproductive Services, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Connecticut Health Center, Farmington, Connecticut, USA

Received 12 November 2003; received in revised form 18 March 2004; accepted 18 March 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0015-0282(04)02223-X

doi:10.1016/j.fertnstert.2004.03.055

Fertility and Sterility
Volume 82, Issue 4 , Pages 841-846, October 2004

Article Tools

* Image Usage & Resolution